| Recruiting | Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patie NCT06409013 | Mayo Clinic | — |
| Recruiting | Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With NCT06129903 | Memorial Sloan Kettering Cancer Center | N/A |
| Recruiting | A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Su NCT05621668 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Cancer NCT05746429 | St. Jude Children's Research Hospital | N/A |
| Active Not Recruiting | In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable a NCT04616248 | University of Southern California | Phase 1 |
| Withdrawn | Gemcitabine With Ascorbate Including Adolescents NCT04877587 | David Dickens | EARLY_Phase 1 |
| Not Yet Recruiting | Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas NCT05515068 | Klinikum Stuttgart | — |
| Withdrawn | Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma NCT05116800 | Brown University | Phase 2 |
| Recruiting | Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone NCT05033288 | Mayo Clinic | — |
| Completed | Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' Resista NCT06202599 | Peking University People's Hospital | — |
| Recruiting | Assessment of the Functional Outcome and Quality of Life in Sarcoma Patients NCT05051059 | Universitaire Ziekenhuizen KU Leuven | N/A |
| Withdrawn | A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas NCT04906876 | Brown University | Phase 2 |
| Completed | Exercise Intervention for Bone Tumor Patients NCT04963517 | Universität Duisburg-Essen | Phase 2 / Phase 3 |
| Recruiting | Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcoma NCT04698785 | Centre Leon Berard | Phase 2 |
| Recruiting | Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas NCT06669013 | N.N. Petrov National Medical Research Center of Oncology | Phase 3 |
| Active Not Recruiting | Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot) NCT04634227 | University of Iowa | EARLY_Phase 1 |
| Recruiting | Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sar NCT04055220 | Centre Leon Berard | N/A |
| Recruiting | Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWO NCT04181970 | Grupo Espanol de Investigacion en Sarcomas | — |
| Terminated | Gemcitabine Plus Ascorbate for Sarcoma in Adults NCT03468075 | Mohammed Milhem, MBBS | Phase 2 |
| Unknown | NY-ESO-1-specific T Cell Receptor (TCR) T Cell in Sarcoma NCT03462316 | Sun Yat-sen University | Phase 1 |
| Active Not Recruiting | LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Ca NCT03449108 | M.D. Anderson Cancer Center | Phase 2 |
| Enrolling By Invitation | LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology NCT03244020 | Massachusetts General Hospital | Phase 4 |
| Recruiting | Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas NCT03442465 | Memorial Sloan Kettering Cancer Center | — |
| Unknown | A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma NCT02982486 | Assaf-Harofeh Medical Center | Phase 2 |
| Completed | Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas NCT03277924 | Grupo Espanol de Investigacion en Sarcomas | Phase 1 / Phase 2 |
| Completed | A Study of IMRT in Primary Bone and Soft Tissue Sarcoma NCT02520128 | University College, London | N/A |
| Recruiting | In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma NCT02811523 | University Health Network, Toronto | Phase 1 |
| Completed | SARC028: A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas NCT02301039 | Sarcoma Alliance for Research through Collaboration | Phase 2 |
| Completed | Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Pa NCT02384473 | University of Southern California | EARLY_Phase 1 |
| Completed | Dendritic Cell Vaccine for Children and Adults With Sarcoma NCT01803152 | Macarena De La Fuente, MD | Phase 1 |
| Completed | Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI NCT01336803 | Heike E Daldrup-Link | Phase 2 |
| Completed | Proton Radiation for the Treatment of Pediatric Bone and Non-Rhabdomyosarcoma Soft Tissue Sarcomas NCT00592293 | Massachusetts General Hospital | N/A |
| Completed | Dalteparin in Preventing DVT in Participants With Cancer NCT00525057 | M.D. Anderson Cancer Center | N/A |